The histone deacetylase inhibitor, vorinostat, reduces tumor growth at the metastatic bone site and associated osteolysis, but promotes normal bone loss. (Record no. 20448732)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01986 a2200565 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250516015043.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 201103s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1538-8514 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1158/1535-7163.MCT-10-0572 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Pratap, Jitesh |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20110328 |
245 00 - TITLE STATEMENT | |
Title | The histone deacetylase inhibitor, vorinostat, reduces tumor growth at the metastatic bone site and associated osteolysis, but promotes normal bone loss. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Molecular cancer therapeutics |
Date of publication, distribution, etc. | Dec 2010 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 3210-20 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Journal Article; Research Support, N.I.H., Extramural |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Animals |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Bone Neoplasms |
General subdivision | complications |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Bone Resorption |
General subdivision | complications |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Bone and Bones |
General subdivision | diagnostic imaging |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Cell Line, Tumor |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Cell Proliferation |
General subdivision | drug effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Extremities |
General subdivision | pathology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Histone Deacetylase Inhibitors |
General subdivision | chemistry |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Hydroxamic Acids |
General subdivision | chemistry |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Mice |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Mice, SCID |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Osteolysis |
General subdivision | complications |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Radiography |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Tumor Burden |
General subdivision | drug effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Tumor Microenvironment |
General subdivision | drug effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Vorinostat |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Xenograft Model Antitumor Assays |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Akech, Jacqueline |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Wixted, John J |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Szabo, Gabriela |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Hussain, Sadiq |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | McGee-Lawrence, Meghan E |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Li, Xiaodong |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Bedard, Krystin |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Dhillon, Robinder J |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | van Wijnen, Andre J |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Stein, Janet L |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Stein, Gary S |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Westendorf, Jennifer J |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Lian, Jane B |
773 0# - HOST ITEM ENTRY | |
Title | Molecular cancer therapeutics |
Related parts | vol. 9 |
-- | no. 12 |
-- | p. 3210-20 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1158/1535-7163.MCT-10-0572">https://doi.org/10.1158/1535-7163.MCT-10-0572</a> |
Public note | Available from publisher's website |
No items available.